MedTrace Logo

Qudratus Lumborum Block for Postoperative Pain After Endoscopic Prostatectomy.

NCT03600129 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-10-22

No results posted yet for this study

Summary

Laparoscopic prostatectomy (LP) is characterized by substantial tissue trauma, despite its minimally -invasive approach. Although postoperative pain intensity is lower when compared to open procedures, the use of opioids is common. Retrospective review of available LP cases revealed that although analgesic demand varied, nearly all of our LP patients required opioids postoperatively. Bilateral Quadratus Lumborum Block (QLB), being one of relatively new features of regional anesthesia, offers good analgesia of abdominal wall, with the potential for control of visceral pain. This study was established to evaluate its effectiveness in alleviating pain after radical prostatectomy in a double - blind, placebo - controlled manner.

Conditions

Interventions

PROCEDURE

Qadratus Lumborum Block

Bilateral, ultrasound - guided Quadratus Lumborum Block

DRUG

30 milliliters of 0.375% Ropivacaine

30 milliliters of 0.375% Ropivacaine used for Quadratus Lumborum Block

DRUG

30 milliliters of 0.9% NaCl

30 milliliters of 0.9% NaCl used for Quadratus Lumborum Block

Sponsors & Collaborators

  • Centre of Postgraduate Medical Education

    lead OTHER

Principal Investigators

  • Malgorzata Malec-Milewska, MD, PhD · Orlowski Hospital, Centre of Postgraduate Medical Education, Department of Anesthesiology and Intensive Care

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-25
Primary Completion
2019-10-21
Completion
2019-10-21

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03600129 on ClinicalTrials.gov